Susan Hoffstetter1, Fah Che Leong. 1. Saint Louis University, School of Medicine, Department of Obstetrics, Gynecology and Women's Health, St. Louis, MO 63117, USA. hoffstes@slu.edu
Abstract
UNLABELLED: Solifenacin succinate, a competitive muscarinic receptor antagonist, is one of the newer options for the treatment of overactive bladder in men and women. OBJECTIVE: To review the pharmacology, efficacy and tolerability for the treatment of overactive bladder with solifenacin succinate. METHODS: A literature search was done using the keywords YM905 and solifenacin succinate. CONCLUSION: Solifenacin succinate was shown to be effective for symptom control with an increase in volume voided, improvement in quality of life and a decrease in a common side effect of dry mouth compared to other medications.
UNLABELLED: Solifenacin succinate, a competitive muscarinic receptor antagonist, is one of the newer options for the treatment of overactive bladder in men and women. OBJECTIVE: To review the pharmacology, efficacy and tolerability for the treatment of overactive bladder with solifenacin succinate. METHODS: A literature search was done using the keywords YM905 and solifenacin succinate. CONCLUSION:Solifenacin succinate was shown to be effective for symptom control with an increase in volume voided, improvement in quality of life and a decrease in a common side effect of dry mouth compared to other medications.
Authors: Krystal J Thomas-White; Evann E Hilt; Cynthia Fok; Meghan M Pearce; Elizabeth R Mueller; Stephanie Kliethermes; Kristin Jacobs; Michael J Zilliox; Cynthia Brincat; Travis K Price; Gina Kuffel; Paul Schreckenberger; Xiaowu Gai; Linda Brubaker; Alan J Wolfe Journal: Int Urogynecol J Date: 2015-09-30 Impact factor: 2.894
Authors: Önder Ercan; Bülent Köstü; Murat Bakacak; Yusuf Aytaç-Tohma; Bora Çoşkun; Fazıl Avcı; Erkan Efe Journal: Saudi Med J Date: 2015-10 Impact factor: 1.484